The Systolic Hypertension in the Elderly Program
|
|
- Laurence Parks
- 5 years ago
- Views:
Transcription
1 44 Blood Pressure Treatment Slows the Progression of Carotid Stenosis in Patients With Isolated Systolic Hypertension Kim Sutton-Tyrrell, DrPH; Sidney K. Wolfson, Jr, MD; Lewis H. Kuller, MD Background and Purpose The Systolic Hypertension in the Elderly Program (SHEP) was a randomized trial testing the efficacy of treating systolic hypertension in older adults. A significant reduction in stroke risk was observed among participants assigned to active treatment. Serial carotid duplex scans were performed on 129 participants at the University of Pittsburgh center, and rates of progression and regression of carotid stenosis were observed. Methods Changes in blood flow velocity ratios were used to detect progression because they can be reliably measured and their relation to degree of residual lumen is known. Progression required the development of a 40% to 50% diameter stenosis when stenosis was not initially present or, if already present, further reduction in the lumen diameter. Regression required the absence of a 40% to 50% diameter stenosis when stenosis was initially present or a stenosis significantly less severe than that initially seen. The Systolic Hypertension in the Elderly Program (SHEP) has shown that the treatment of systolic hypertension reduces the risk of both stroke and cardiovascular disease. 1 This may result from a slowing of atherosclerosis progression when blood pressure is controlled. Serial duplex scans of the carotid arteries (two scans separated by 2 years) were obtained in 129 SHEP participants at the University of Pittsburgh field center. These data were evaluated to determine the effect of blood pressure treatment on progression of carotid artery stenosis. Methods SHEP was a randomized, placebo-controlled trial to test the efficacy of treatment of isolated systolic hypertension in adults over age Participants randomized to active treatment received a diuretic and/or /3-blocker for blood pressure control. Those randomized to placebo received matching placebo medication. Results of SHEP demonstrated a 36% reduction in stroke incidence among the active treatment group. 1 As part of an ancillary study of peripheral atherosclerosis, participants at the University of Pittsburgh field center were invited to undergo duplex scanning of the carotid arteries. Two Received August 13, 1993; final revision received September 27, 1993; accepted October 11, From the Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh (K.S.-T., L.H.K.), and the Department of Surgery, School of Medicine and Montefiore University Hospital, University of Pittsburgh (S.K.W.), Pa. Correspondence to Kim Sutton-Tyrrell, DrPH, Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, 130 DeSoto St, Pittsburgh, PA 151. Results Progression occurred in 22% (28/129) of participants and regression in 16% (8/49). Progression of carotid stenosis occurred more often among participants randomized to placebo as compared with active treatment (31% versus 14%, P=.Q20). All eight patients exhibiting regression were randomized to active treatment. In multivariate analysis, participants assigned to placebo had 4.3 times greater odds of progressing than participants assigned to active treatment. Other factors significantly related to progression were higher degree of plaque at baseline, low high-density lipoprotein-3, high lipoprotein(a), and younger age. Conclusions Treating systolic hypertension appears to slow progression of carotid stenosis. Similar effects occurring in the intracranial vessels may be one reason for the substantial decrease in stroke among SHEP participants assigned to active treatment. (Stroke. 1994;:44-50.) Key Words carotid artery disease hypertension stenosis duplex scans were performed separated by 2 years. For all participants, the baseline scan was performed after they began taking active or placebo medication. The 129 individuals included in this report were consecutive participants who had their baseline scan at least 6 months before the end of the SHEP trial. The average time from SHEP entry to the baseline scan was 42 months. There was an average of months between the two scans with a range of 21 to 34 months. Participants underwent duplex scanning at the Peripheral Vascular Diagnostic Laboratory located in Montefiore University Hospital, Pittsburgh, Pa. Both baseline and follow-up scans were performed using a Diasonics DRF 400 duplex scanner (Milpitas, Calif) with a 10-MHz imaging probe and 4.5-MHz Doppler. B-mode images were used to assess minimal to moderate disease that had not yet caused changes in blood flow. Scans were recorded on videotape for later scoring. A reader assigned a grade from 0 to 3 to each of seven segments in the carotid system based on the number and size of lesions present. Plaque grades from segments in the common carotid artery (CCA), carotid bulb, and internal carotid artery (ICA) from both the right and left carotid systems then were summed to create a measure of extent of atherosclerotic plaque called the plaque index. A complete discussion of this method has been previously published. 3 ' 4 Doppler measures of blood flow velocity were used to determine the presence of a carotid stenosis. Doppler measurements obtained by duplex scanning have shown good agreement with angiography in the identification of carotid stenosis. 58 Visual estimates of stenosis can vary greatly, especially when plaque formation is asymmetric. This is because the apparent size of an asymmetric plaque and the associated residual lumen changes depending on the angle of evaluation. As a vessel lumen narrows, regardless of the symmetry of plaque formation, the velocity of blood flow at
2 Sutton-Tyrrell et al Stenosis Progression and Blood Pressure 45 TABLE 1. Carotid Disease Progression and Regression in the Pittsburgh SHEP Cohort Carotid Systems (n=8) Participants (n=129) Progression ICA ECA CCA/Bulb Any location Regression ICA ECA CCA/Bulb Any location n % SHEP indicates Systolic Hypertension in the Elderly Program; ICA, internal carotid artery; ECA, external carotid artery; and CCA, common carotid artery n % that site increases. This direct relation between blood velocity and residual vessel lumen makes the quantification of stenosis by Doppler more accurate than visual estimates of stenosis Assuming that the CCA is relatively free of significant disease, the ratio of internal carotid blood flow velocity to common carotid blood flow velocity (ICA-CCA ratio) is a measure of stenosis that controls for intersubject variation. 5 ICA stenosis was defined as an ICA velocity of 90 mm/s or greater accompanied by an ICA-CCA ratio of 1.4 or above. This definition was based on studies comparing velocity ratios in normal patients with ratios in patients with angiographically documented carotid stenosis. 5 ' 11 This corresponds to a luminal diameter reduction of approximately 40% to 50% or greater. 9 While this definition does not always represent clinically important disease, it represents the lowest level of disease that can be reliably detected by Doppler scan. Velocity ratios were also used to determine carotid stenoses in the external carotid artery (ECA), carotid bulb, and CCA by comparing the elevated velocity in the location of interest with the velocity in a relatively normal portion of the CCA proximal to the area of interest. In these locations, stenosis was defined as a velocity of 100 mm/s or greater at the area of interest accompanied by a velocity ratio of 1.4 or greater. At the beginning of the study, a decision was made that progression of disease would include all areas of the carotid system, not just the ICA. Before analysis of the data, changes in the bloodflowvelocity and velocity ratios were used to ascertain progression. Because Doppler measures are not useful in detecting stenoses of less than 40% to 50% diameter reduction, progression or regression of disease less than this could not be included. Progression was defined as the development of 40% to 50% stenosis when stenosis was not present on the first scan or, if a stenosis was already present, further reduction in the cross-sectional luminal diameter. More specifically, progression in the ICA required an increase in blood flow velocity of at least 20 mm/s to at least 90 mm/s, accompanied by an increase in the ICA-CCA ratio of at least 0.4 to at least 1.4. Criteria for the ECA were more stringent, requiring an increase in blood flow velocity of at least 30 mm/s to at least 100 mm/s and an increase in the ECA-CCA ratio of at least 0.4 to at least 1.4. Criteria for the CCA and carotid bulb were even more stringent, requiring an increase in bloodflowvelocity of at least 40 mm/s and an increase in the velocity ratio of at least 0.4 to at least 1.4. Finally, for any artery, if a velocity of 140 mm/s or greater was present on the baseline scan, the requirement for increase in bloodflowvelocity was raised to 40 mrn/s. A vessel exhibiting a high velocity at baseline and found to be occluded at follow-up was also considered progression. To explore the possibility of regression of carotid stenosis, the algorithm for progression was executed in reverse, comparing the second scan with the first. For example, for the ICA, blood flow velocity had to decrease by 20 mm/s accompanied by a reduction of the ICA-CCA ratio of 0.4. If the ICA velocity remained 140 mm/s or greater on the second scan, then a decrease in velocity of 40 mm/s or greater was required accompanied by a reduction in the ICA-CCA ratio of at least 0.4. Regression could therefore only be identified if a stenosis was present at baseline. The study was conducted under a strict research protocol designed to reduce measurement error. Two sonographers performed 95% (6/8) of all scans. Peak blood flow velocities and velocity ratios obtained by these sonographers were highly reproducible in participants who had duplicate scans on the same day. 4 When progression and regression definitions were applied to these duplicate scans, 3% of patients showed progression and 3% showed regression. These represent the error rates in our measurement of progression and regression. Fasting blood samples were drawn at the time of the baseline carotid scan for determination of lipids and glucose. Standard laboratory methods were used to evaluate triglycerides, total cholesterol, high-density lipoprotein (HDL) cholesterol, HDL-2, HDL-3, apoproteins Al and A2, and apoprotein B. Low-density lipoprotein (LDL) cholesterol was estimated using the Friedwald equation. 12 Lipoprotein(a) (Lp[a]) was measured using a commercially available kit that employs an enzyme-linked immunosorbant assay. A x 2 test was used to determine the significance of differences in proportions, with Fisher's exact test used where appropriate. Differences in means were determined by a t test for normally distributed variables and a Wilcoxon test for variables not normally distributed. Independent predictors of progression were determined by logistic regression. The Wilcoxon signed-rank test for paired data was used to determine differences in the plaque index between baseline and follow-up scans. Finally, multiple linear regression was used to determine the relation between treatment assignment and change in plaque index while controlling for baseline differences between active and placebo groups. A value of/"=.o5 was considered significant. Results risk factors were compared between the 129 individuals in this ancillary study and the full SHEP cohort. The only factor that was significantly different was smoking history. Individuals in the ancillary study were significantly less likely to have ever smoked com-
3 46 Stroke Vol, No 1 January 1994 TABLE 2. Raw Velocity Data for 38 Arteries (34 Participants) Showing Progression Months Between Scans ICA Occlusion Occlusion ECA CCA/Bulb ICA indicates internal carotid artery; ECA, external carotid artery; and CCA, common carotid artery. pared with the full SHEP cohort (37% versus 50%, P<.001). Progression occurred in 22% (28/129) of participants. Regression could only be assessed in the subgroup of 49 patients that had a stenosis (any location) at baseline. Of this subgroup, 8 participants (16%) showed regression. Progression was seen primarily in the ICA (21 arteries), but was also observed in the ECA (15 arteries) and CCA or bulb (1 CCA, 1 bulb) (Table 1). The median increase in blood flow velocity for ICAs that progressed was 52 mm/s compared with 1 mm/s for ICAs not showing progression. Those showing regression had a median decrease in blood flow velocity of 40 mm/s. Similar results were seen for the ECA. Raw blood flow velocity data for arteries showing progression and regression are presented in Tables 2 and 3.
4 Sutton-Tyrrell et al Stenosis Progression and Blood Pressure 47 TABLE 3. ICA ECA Raw Velocity Data for 11 Arteries (8 Participants) Showing Regression ICA indicates internal carotid artery; ECA, external carotid artery Months Between Scans 21 Before analyzing results by treatment assignment, the active and placebo groups were compared with respect to baseline risk factors (Table 4). The two groups were similar, although the active treatment group had a significantly higher median Lp(a) value, a lower proportion of males, a higher mean HDL level, and were less likely to have ever smoked. The mean number of months between scans was.9 for the active treatment group and.0 for the placebo group. In univariate analysis, 31% of those randomized to placebo progressed whereas only 14% of those randomized to active treatment progressed (P=.O2O, Table 5). All 8 patients who showed regression were randomized to active treatment. Among the group with a stenosis at baseline, 32% (8/) of active treatment participants regressed versus 0% (0/) of placebo participants (/>=.004, Fisher's exact test; Table 5). Several other factors were found to be related to progression, the strongest of which was the degree of plaque observed on the baseline scan. Progression rates ranged from 3% among those with a plaque index less than 3 to 54% among those with a plaque index of 9 or greater (Figure). Other baseline variables significantly related to progression were higher Lp(a), apoprotein B or triglycerides, and lower HDL, HDL-2, or HDL-3 (Table 6). Mean reduction in pretreatment blood pressure was less for those who progressed than those who did not (18 mm Hg versus mm Hg), although this relation did not reach statistical significance. Stepwise logistic regression was used to determine whether SHEP treatment assignment was independently associated with progression (Table 7). In this model, placebo treatment assignment was associated with 4.3 times greater odds of progression than an active TABLE 4. Differences in Variables Between Participants Randomized to Active Treatment Versus Placebo Mean age, y Median baseline systolic BP, mm Hg Median baseline diastolic BP, mm Hg Median triglycerides Mean total cholesterol Mean HDL cholesterol Mean HDL-2 Mean HDL-3 Mean LDL Mean apoprotein B Median lipoprotein(a) Median plaque index %Male % Ever smokers Active (n=71) Placebo (n=58) BP indicates blood pressure; HDL, high-density lipoprotein; and LDL, low-density lipoprotein. Laboratory values reported in mg/dl. P
5 48 Stroke Vol, No 1 January 1994 TABLE 5. Progression and Regression* of Carotid Stenosis by SHEP Treatment Assignment % Showing Progression 100 N n % Active ,1 Placebo Progression Regression* Active Placebo Regression could only be assessed in participants who had a stenosis (any location) at baseline. treatment assignment. Additional variables related to progression were greater extent of plaque at baseline, HDL-3 <30 mg/dl, Lp(a) >20 mg/dl, and younger age. Other variables that were significantly associated with progression in univariate analysis were no longer significant after controlling for the variables listed above. Years of smoking, HDL (in place of HDL-3), and diastolic blood pressure contributed little to the model and were therefore removed. While the B-mode information was not the primary focus of this study, the plaque index was analyzed to determine if treatment assignment was also related to an increase in extent of plaque. For the group as a whole, the plaque index was significantly higher for the follow-up scans compared with baseline. The mean plaque index was 4.8 at baseline and 5.7 at follow-up (/><.001). The average change in plaque index was The average change was higher for the placebo group ( + 1.) compared with the active treatment group (+0.61). While this difference was not statistically significant in univariate analysis (P=.O9O), it was significant after adjusting for baseline differences between active and placebo groups (/>=.050). Changes in the plaque index for those with and without stenosis progression were also compared. The average change in plaque index was for those Plaque Index 9+ Relation between degree of plaque at baseline and rates of carotid stenosis progression. The plaque index was calculated by scoring the number and size of plaques in the common carotid artery, carotid bulb, and internal carotid artery. without a stenosis progression compared with for those with a stenosis progression (P=.O27). Discussion This study provides strong evidence that the treatment of isolated systolic hypertension slows the rate of carotid stenosis progression. The primary analysis defined progression in terms of blood flow because we believe that this is the best index of atherosclerosis when dealing with a population that has a high prevalence of advanced disease. Doppler measures were highly reproducible and observed progression rates were much higher than those that would have been due to measurement error alone. The use of blood flow velocity ratios in the progression definition has the advantage of controlling for other factors that may affect blood flow velocity. Such factors would have affected the CCA as well as areas more distal in the carotid system. There is much evidence to suggest that disease in the carotid arteries is a marker for generalized systemic ath- TABLE 6. Differences in Variables Between Participants Who Did and Did Not Show Progression of Carotid Stenosis Progression (n=28) No Progression (n=101) P Mean reduction in systolic BP from baseline, mm Hg Mean age, y Median triglycerides Mean total cholesterol Mean HDL cholesterol Mean HDL-2 Mean HDL Mean LDL Mean apoprotein B Median lipoprotein(a) % Ever smokers BP indicates blood pressure; HDL, high-density lipoprotein; and LDL, low-density lipoprotein. Laboratory values reported in mg/dl.
6 Sutton-Tyrrell et al Stenosis Progression and Blood Pressure 49 TABLE 7. Variable Independent Predictors of Carotid Stenosis Progression Placebo treatment assignment Plaque index (each 3-unit increment) HDL-3 <30 mg/dl Lipoprotein(a) >20 mg/dl Age (each 10-year increment) Male HDL indicates high-density lipoprotein. Odds Ratio % Confidence Interval P erosclerosis Past studies have focused primarily on the ICA because of its clinical relation to stroke. Whereas disease in other areas of the carotid system is not always clinically important, researchers have begun to use such disease as a marker for generalized atherosclerosis The progression definition used here thus encompassed all areas of the carotid system, not just the ICA. Other studies of carotid disease have used a variety of techniques to measure progression. Some studies have categorized carotid disease by use of angiography 17 or Doppler spectral analysis, 18 while others have focused specifically on changing characteristics of plaques. 19 More recently, authors have concentrated on change in intima-media thickness over time Intima-media thickness measures are not yet available for this study because these techniques were not well documented at the time data collection was initiated. However, analysis of B-mode data in the form of the plaque index suggests that progression of carotid stenosis was accompanied by a progression of atherosclerotic plaque. It has been shown that treatment of systolic hypertension reduces the risk of stroke,1 - and this effect occurs within a year or two after blood pressure treatment. This rapid response to treatment may involve pathophysiological mechanisms over and above a delay in progression of individual plaques. In addition to lowering blood pressure, antihypertensive therapy may also cause changes in distal small vessel reactivity or changes in arterial wave propagation. Either or both of these may contribute to a reduction in cardiovascular events. Previous studies have shown a direct relation between the degree of carotid stenosis and risk of both stroke and coronary heart disease. 14 We have previously shown that individuals with isolated systolic hypertension have a much higher prevalence of carotid stenosis than age-similar normotensive control subjects. 3 The treatment effect on carotid stenosis presented here may be a demonstration of what is ongoing in the intracranial and coronary vessels. This is likely to be at least part of the reason for the reduction in stroke and myocardial infarction risk among SHEP participants randomized to active blood pressure treatment. One weakness of this study is that the duplex scans were not obtained earlier in the study, before treatment. Unfortunately, the SHEP trial ended before all participants had completed their follow-up scans. Observed treatment effects would probably have been stronger if the scans could have been performed earlier, and more conclusive data on regression might have been obtained. In previous literature, the most consistent factor found to be related to progression has been higher degree of carotid disease at baseline, and this is consistent with the results reported here. Interestingly, older participants were less likely to progress than younger participants. This may have resulted from a selection bias related to the exclusion criteria for the SHEP trial. Older individuals were more likely to have advanced atherosclerosis and therefore be excluded. This may have caused the study population to have an under-representation of older individuals who would have been most likely to progress. Similar results published by Roederer et al 18 reported that patients under 65 years of age were most likely to show progression. Other studies have shown relations between various lipid levels and carotid disease progression including higher total cholesterol, 21 triglycerides 19 and LDL, 20 and lower HDL. 19 This study demonstrated similar results, but in multivariate analysis a high Lp(a) and a low HDL-3 were found to be the most important lipids associated with progression. In conclusion, this study provides strong evidence of a major treatment effect on carotid artery stenosis and progression of plaque among participants in SHEP. With treatment of isolated systolic hypertension, progression of stenosis is slowed and it is possible that regression occurs. Similar effects occurring in the coronary and intracranial vessels are likely to be part of the reason for the reduction in stroke and myocardial infarction risk among SHEP participants randomized to active blood pressure treatment. Acknowledgment This study was supported by National Institutes of Health grant HL References 1. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA. 1991;5: Black HR, Curb JD, Pressel S, Probstfield JL, Stamler J, eds. Systolic Hypertension in the Elderly Program (SHEP): baseline characteristics of the randomized sample. Hypertension. 1991; 17(suppl II):II-1-II Sutton-Tyrrell K, Alcorn H, Wolfson SK. Predictors of carotid stenosis in older adults with and without isolated systolic hypertension. Circulation. 1993;: Sutton-Tyrrell K, Wolfson SK, Thompson T, Kelsey SF. Measurement variability in duplex scan assessment of carotid atherosclerosis. Stroke. 1992;: Blackshear W, Phillips DJ, Chikos PM, Harley JD, Thiele BL, Strandness DE. Carotid artery velocity patterns in normal and stenotic vessels. Stroke. 1980;l 1:67-71.
7 50 Stroke Vol, No 1 January Glover JL, Bendick PJ, Jackson VP, Becker GJ, Dilley RS, Holden RW. Duplex ultrasonography, digital subtraction angiography and conventional angiography in assessing carotid atherosclerosis. Arch Surg. 1984;119: Blackshear WM, Lamb SL, Kollipara VSK, Anderson JD, Murtagh FR, Shah CP, Farber MS. Correlation of hemodynamically significant internal carotid stenosis with pulsed Doppler frequency analysis. Ann Surg. 1984;199: Wetzner SM, Kiser LC, Bezreh JS. Duplex ultrasound imaging: vascular applications. Radiology. 1984;150: Spencer MP, Reid JM. Quantitation of carotid stenosis with continuous wave (C-W) Doppler ultrasound. Stroke. 1979;10: Alexandrov AV, Bladin CF, Maggisano R, Norris JW. Measuring carotid stenosis: time for a reappraisal. Stroke. 1993;: Keagy BA, Pharr WF, Thomas D, Bowes DE. A quantitative method for the evaluation of spectral analysis patterns in carotid artery stenosis. Ultrasound Med Biol. 1982;8: Friedwald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972; 18: Sutton KC, Wolfson SK, Kuller LH. Carotid and lower extremity arterial disease in elderly adults with isolated systolic hypertension. Stroke. 1987;18: Norris JW, Zhu CZ, Bornstein NM, Chambers BR. Vascular risks of asymptomatic carotid stenosis. Stroke. 1991;22: Salonen R, Haapanen A, Salonen JT. Measurement of intima-media thickness of common carotid arteries with high-resolution B-mode ultrasonography: inter- and intra-observer variability. Ultrasound MedBiol 1991;17: O'Leary DH, Polak JF, Wolfson SK, Bond MG, Bommer W, Sheth S, Psaty BM, Sharrett AR, Manolio TA. Use of sonography to evaluate carotid atherosclerosis in the elderly: the Cardiovascular Health Study. Stroke. 1991;22: Kuo PT, Toole JF, Schaaf JA, Jones A, Wilson AC, Kostis JB, Moreyra AE. Exlracranial carotid arterial disease in patients with familial hypercholesterolemia and coronary artery disease treated with colestipol and nicotinic acid. Stroke. 1987;18: Roederer GO, Langlois YE, Jager KA, Primozich JF, Beach KW, Phillips DJ, Strandness DE. The natural history of carotid arterial disease in asymptomatic patients with cervical bruits. Stroke. 1984; 15: Hennerici M, Rautenberg W, Trockel U, Kladetzky RG. Spontaneous progression and regression of small carotid atheroma. Lancet. 1985;1: Salonen R, Salonen JT. Progression of carotid atherosclerosis and its determinants: a population-based ultrasonography study. Atherosclerosis. 1990;81: Tanaka H, Nishino M, Ishida M, Fukunaga R, Sueyoshi K. Progression of carotid atherosclerosis in Japanese patients with coronary artery disease. Stroke. 1992;: Bond MG, Strickland HL, Wilmoth SK, Safrit A, Phillips R, Szostak L for the MIDAS Research Group. Interventional clinical trials using noninvasive ultrasound endpoints: the multicenter isradipine/diuretic atherosclerosis study. J Cardiovasc Pharmacol. 1990;15(suppl l):s30-s33.. MRC Working Party. Medical research council trial of treatment of hypertension in older adults: principal results. BMJ. 1992;304: Beard K, Bulpitt C, Mascie-Taylor H, O'Malley K, Sever P, Webb S. Management of elderly patients with sustained hypertension. BMJ. 1992;304: Senin U, Parnetti L, Mercuri M, Lupattelli G, Susta A, Ciuffetti G. Evolutionary trends in carotid atherosclerotic plaques: results of a two-year follow-up study using an ultrasound imaging system. Angiology. 1988;39:
Progression of Carotid Atherosclerosis in Japanese Patients With Coronary Artery Disease
946 Progression of Carotid Atherosclerosis in Japanese Patients With Coronary Artery Disease Hidekazu Tanaka, MD; Masami Nishino, MD; Mariko Ishida, MD; Ryuzo Fukunaga, MD, PhD; and Kenji Sueyoshi, MD,
More information(Department of Radiology, Beylikdüzü State Hospital, İstanbul, Turkey) Corresponding Author: Dr. Mete Özdikici
Quest Journals Journal of Medical and Dental Science Research Volume 5~ Issue 6 (2018) pp: 61-65 ISSN(Online) : 2394-076X ISSN (Print):2394-0751 www.questjournals.org Research Paper Quantitative Measurements
More informationRange-Gated Pulsed Doppler Power Frequency Spectrum Analysis for the Diagnosis of Carotid Arterial Occlusive Disease
924 Range-Gated Pulsed Doppler Power Frequency Spectrum Analysis for the Diagnosis of Carotid Arterial Occlusive Disease TIMOTHY R. S. HARWARD, M.D., EUGENE F. BERNSTEIN, M.D., PH.D.,* AND ARNOST FRONEK,
More informationMORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS. 73 year old NS right-handed male applicant for $1 Million life insurance
MORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS October 17, 2012 AAIM Triennial Conference, San Diego Robert Lund, MD What Is The Risk? 73 year old NS right-handed male applicant for $1
More informationCategorical Course: Update of Doppler US 8 : 00 8 : 20
159 Categorical Course: Update of Doppler US 8 : 00 8 : 20 160 161 Table 1.Comparison of Recommended Values from Data in the Published Literature* S t u d y Lesion PSV E D V VICA/VCCA S e v e r i t y (
More informationEVALUATION OF CAROTID ARTERY STENOSIS IN STROKE/TRANSIENT ISCHAEMIC ATTACK Nambakam Tanuja Subramanyam 1, Naveen Kumar P 2, Girish P.
EVALUATION OF CAROTID ARTERY STENOSIS IN STROKE/TRANSIENT ISCHAEMIC ATTACK Nambakam Tanuja Subramanyam 1, Naveen Kumar P 2, Girish P. Vakrani 3 HOW TO CITE THIS ARTICLE: Nambakam Tanuja Subramanyam, Naveen
More informationCoronary artery disease (CAD) risk factors
Background Coronary artery disease (CAD) risk factors CAD Risk factors Hypertension Insulin resistance /diabetes Dyslipidemia Smoking /Obesity Male gender/ Old age Atherosclerosis Arterial stiffness precedes
More informationMORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS. 73 year old NS right-handed male applicant for $1 Million Life Insurance
MORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS October 17, 2012 AAIM Triennial Conference, San Diego Robert Lund, MD What Is The Risk? 73 year old NS right-handed male applicant for $1
More informationAsian J. Exp. Sci., Vol. 27, No. 1, 2013; 67-72
Carotid Intima-media Thickness as a Surrogate Marker of Atherosclerosis and its Correlation with Coronary Risk Factors and Angiographic Severity of Coronary Artery Disease. 1 2 Rajeev Gupta and Rajendra
More informationGUNDERSEN/LUTHERAN ULTRASOUND DEPARTMENT POLICY AND PROCEDURE MANUAL
GUNDERSEN/LUTHERAN ULTRASOUND DEPARTMENT POLICY AND PROCEDURE MANUAL SUBJECT: Carotid Duplex Ultrasound SECTION: Vascular Ultrasound ORIGINATOR: Deborah L. Richert, BSVT, RDMS, RVT DATE: October 15, 2015
More informationORIGINAL CONTRIBUTION. Long-term Risk of Stroke and Other Vascular Events in Patients With Asymptomatic Carotid Artery Stenosis
ORIGINAL CONTRIBUTION Long-term Risk of Stroke and Other Vascular Events in Patients With Asymptomatic Carotid Artery Stenosis Zurab G. Nadareishvili, MD, PhD; Peter M. Rothwell, MD, PhD; Vadim Beletsky,
More informationDuplex Criteria for Determination of 50% or Greater Carotid Stenosis
Article Duplex Criteria for Determination of 50% or Greater Carotid Stenosis David G. Neschis, MD, Frank J. Lexa, MD, Julia T. Davis, RN, RVT, Jeffrey P. Carpenter, MD, RVT Recently the North American
More informationIntima-Media Thickness
European Society of Cardiology Stockholm, 30th August 2010 Intima-Media Thickness Integration of arterial assessment into clinical practice Prof Arno Schmidt-Trucksäss, MD Institute of Exercise and Health
More informationCarotid Abnormalities Coils, Kinks and Tortuosity David Lorelli M.D., RVT, FACS Michigan Vascular Association Conference Saturday, October 20, 2012
Carotid Abnormalities Coils, Kinks and Tortuosity David Lorelli M.D., RVT, FACS Michigan Vascular Association Conference Saturday, October 20, 2012 Page 1 Table of Contents Carotid Anatomy Carotid Duplex
More informationORIGINAL INVESTIGATION. Relevance of Carotid Stenosis Progression as a Predictor of Ischemic Neurological Outcomes
ORIGINAL INVESTIGATION Relevance of Carotid Stenosis Progression as a Predictor of Ischemic Neurological Outcomes Daniel J. Bertges, MD; Visala Muluk, MD; Jeffrey Whittle, MD, MPH; Mary Kelley, MS; David
More informationPre-and Post Procedure Non-Invasive Evaluation of the Patient with Carotid Disease
Pre-and Post Procedure Non-Invasive Evaluation of the Patient with Carotid Disease Michael R. Jaff, D.O., F.A.C.P., F.A.C.C. Assistant Professor of Medicine Harvard Medical School Director, Vascular Medicine
More informationPrevalence and Significance of Carotid Plaques in Patients With Coronary Atherosclerosis
ORIGINAL ARTICLE DOI 10.4070 / kcj.2009.39.8.317 Print ISSN 1738-5520 / On-line ISSN 1738-5555 Copyright c 2009 The Korean Society of Cardiology Prevalence and Significance of Carotid Plaques in Patients
More informationImaging Biomarkers: utilisation for the purposes of registration. EMEA-EFPIA Workshop on Biomarkers 15 December 2006
Imaging Biomarkers: utilisation for the purposes of registration EMEA-EFPIA Workshop on Biomarkers 15 December 2006 Vascular Imaging Technologies Carotid Ultrasound-IMT IVUS-PAV QCA-% stenosis 2 ICH E
More informationRisk Factors for Ischemic Stroke: Electrocardiographic Findings
Original Articles 232 Risk Factors for Ischemic Stroke: Electrocardiographic Findings Elley H.H. Chiu 1,2, Teng-Yeow Tan 1,3, Ku-Chou Chang 1,3, and Chia-Wei Liou 1,3 Abstract- Background: Standard 12-lead
More informationLDL cholesterol (p = 0.40). However, higher levels of HDL cholesterol (> or =1.5 mmol/l [60 mg/dl]) were associated with less progression of CAC
Am J Cardiol (2004);94:729-32 Relation of degree of physical activity to coronary artery calcium score in asymptomatic individuals with multiple metabolic risk factors M. Y. Desai, et al. Ciccarone Preventive
More informationRisk Factors of Carotid Stenosis in First-Ever Ischemic Stroke in Taiwan: A Hospital-based Study
237 Risk Factors of Carotid Stenosis in First-Ever Ischemic Stroke in Taiwan: A Hospital-based Study Chien-Hung Chang, Yeu-Jhy Chang, Tsong-Hai Lee, Kai-Cheng Hsu, and Shan-Jin Ryu Abstract- Objective:
More informationRole of imaging in risk assessment models: the example of CIMT
Role of imaging in risk assessment models: the example of CIMT Diederick E. Grobbee, MD, PhD, FESC Professor of Clinical Epidemiology Julius Center for Health Sciences and Primary Care, University Medical
More informationDuplex US of the External Carotid Artery
Acta Radiologica ISSN: 0284-1851 (Print) 1600-0455 (Online) Journal homepage: https://www.tandfonline.com/loi/iard20 Duplex US of the External Carotid Artery M. J. Päivänsalo, T. M. J. Siniluoto, T. A.
More informationTitle for Paragraph Format Slide
Title for Paragraph Format Slide Presentation Title: Month Date, Year Atherosclerosis A Spectrum of Disease: February 12, 2015 Richard Cameron Padgett, MD Executive Medical Director, OHVI Pt RB Age 38
More informationImpact of Body Mass Index and Metabolic Syndrome on the Characteristics of Coronary Plaques Using Computed Tomography Angiography
Impact of Body Mass Index and Metabolic Syndrome on the Characteristics of Coronary Plaques Using Computed Tomography Angiography Cardiovascular Division, Faculty of Medicine, University of Tsukuba Akira
More informationVascular disease. Structural evaluation of vascular disease. Goo-Yeong Cho, MD, PhD Seoul National University Bundang Hospital
Vascular disease. Structural evaluation of vascular disease Goo-Yeong Cho, MD, PhD Seoul National University Bundang Hospital resistance vessels : arteries
More informationLow fractional diastolic pressure in the ascending aorta increased the risk of coronary heart disease
(2002) 16, 837 841 & 2002 Nature Publishing Group All rights reserved 0950-9240/02 $25.00 www.nature.com/jhh ORIGINAL ARTICLE Low fractional diastolic pressure in the ascending aorta increased the risk
More informationCarotid artery occlusion: Positive predictive value of duplex sonography compared with arteriography
Carotid artery occlusion: Positive predictive value of duplex sonography compared with arteriography Jonathan D. Kirsch, MD, Louis R. Wagner, MD, E. Meredith James, MD, J. William Charboneau, MD, Douglas
More informationIntermediate Methods in Epidemiology Exercise No. 4 - Passive smoking and atherosclerosis
Intermediate Methods in Epidemiology 2008 Exercise No. 4 - Passive smoking and atherosclerosis The purpose of this exercise is to allow students to recapitulate issues discussed throughout the course which
More informationWhich CVS risk reduction strategy fits better to carotid US findings?
Which CVS risk reduction strategy fits better to carotid US findings? Dougalis A, Soulaidopoulos S, Cholongitas E, Chalevas P, Vettas Ch, Doumtsis P, Vaitsi K, Diavasti M, Mandala E, Garyfallos A 4th Department
More informationPulsed Doppler techniques are commonly used
336 Accurate Noninvasive Method to Diagnose Minor Atherosclerotic Lesions in Carotid Artery Bulb Tiny van Merode, MD, Jan Lodder, MD, Frans A.M. Smeets, Arnold P.G. Hoeks, PhD, and Robert S. Reneman, MD,
More informationScreening for asymptomatic internal artery stenosis: Duplex criteria for discriminating 60% to 99% stenosis
Screening for asymptomatic internal artery stenosis: Duplex criteria for discriminating 60% to 99% stenosis carotid Gregory L. Moneta, MD, James M. Edwards, MD, George Papanicolaou, MD, Thomas Hatsukami,
More informationDuplex Ultrasound of the Renal Arteries. Duplex Ultrasound. In the Beginning
Duplex Ultrasound of the Renal Arteries DIMENSIONS IN HEART AND VASCULAR CARE 2013 PENN STATE HEART AND VASCULAR INSTITUTE ROBERT G. ATNIP MD PROFESSOR OF SURGERY AND RADIOLOGY Duplex Ultrasound Developed
More informationDuplex Carotid Sonography Peak Systolic Velocity in Quantifying Internal Carotid Artery Stenosis
Duplex Carotid Sonography Peak Systolic Velocity in Quantifying Internal Carotid Artery Stenosis Cynthia E Withers, MD", Barbara B Gosink, MD", Alison M Keightley, MD", Giovanna Casola, MD", Arthur A Lee,
More informationCarotid intima media thickness as an usefull tool in predicting cerebrovaskular events
Carotid intima media thickness as an usefull tool in predicting cerebrovaskular events Poster No.: C-0005 Congress: ECR 2015 Type: Authors: Keywords: DOI: Scientific Exhibit A. Rahimic - Catic; Sarajevo/BA
More informationB-Flow, Power Doppler and Color Doppler Ultrasound in the Assessment of Carotid Stenosis: Comparison with 64-MD-CT Angiography
Med. J. Cairo Univ., Vol. 85, No. 2, March: 805-809, 2017 www.medicaljournalofcairouniversity.net B-Flow, Power Doppler and Color Doppler Ultrasound in the Assessment of Carotid Stenosis: Comparison with
More informationData Alert. Vascular Biology Working Group. Blunting the atherosclerotic process in patients with coronary artery disease.
1994--4 Vascular Biology Working Group www.vbwg.org c/o Medical Education Consultants, LLC 25 Sylvan Road South, Westport, CT 688 Chairman: Carl J. Pepine, MD Eminent Scholar American Heart Association
More informationThe New England Journal of Medicine CAROTID-ARTERY INTIMA AND MEDIA THICKNESS AS A RISK FACTOR FOR MYOCARDIAL INFARCTION AND STROKE IN OLDER ADULTS
CAROTID-ARTERY INTIMA AND MEDIA THICKNESS AS A RISK FACTOR FOR MYOCARDIAL INFARCTION AND STROKE IN OLDER ADULTS DANIEL H. O LEARY, M.D., JOSEPH F. POLAK, M.D., M.P.H., RICHARD A. KRONMAL, PH.D., TERI A.
More informationJMSCR Vol 04 Issue 10 Page October 2016
www.jmscr.igmpublication.org Impact Factor 5.244 Index Copernicus Value: 83.27 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v4i10.82 Carotid Intima Media Thickness and Can
More informationUltrasonic Evaluation of Early Carotid Atherosclerosis
1567 Ultrasonic Evaluation of Early Carotid Atherosclerosis Nobuo Handa, MD, PhD, Masayasu Matsumoto, MD, PhD, Hiroaki Maeda, MD, Hidetaka Hougaku, MD, Satoshi Ogawa, MD, Ryuzo Fukunaga, MD, PhD, Shotaro
More informationAutonomic nervous system, inflammation and preclinical carotid atherosclerosis in depressed subjects with coronary risk factors
Autonomic nervous system, inflammation and preclinical carotid atherosclerosis in depressed subjects with coronary risk factors Carmine Pizzi 1 ; Lamberto Manzoli 2, Stefano Mancini 3 ; Gigliola Bedetti
More informationDuplex Doppler Sonography of the Carotid Artery: False-Positive Results in an Artery Contralateral to an Artery with Marked Stenosis
049 Duplex Doppler Sonography of the Carotid Artery: False-Positive Results in an Artery Contralateral to an Artery with Marked Stenosis William W. Beckett, Jr. Patricia C. Davis James C. Hoffman, Jr.
More informationThe presenter does not have any potential conflicts of interest to disclose
Carotid intima-media thickness as a predictor of multi territory atherosclerotic occlusive disease in patients with symptomatic subclavian artery obstruction Leszek Wrotniak 1, Anna Kabłak Ziembicka 1,
More informationDoes color-flow imaging improve the accuracy of duplex carotid evaluation?
Does color-flow imaging improve the accuracy of duplex carotid evaluation? Gregg L. Londrey, MD, Donald P. Spadone, MD, Kim J. Hodgson, MD, Don E. Ramsey, MD, Lynne D. Barkmeier, MD, and David S. Sumner,
More informationProtokollanhang zur SPACE-2-Studie Neurology Quality Standards
Protokollanhang zur SPACE-2-Studie Neurology Quality Standards 1. General remarks In contrast to SPACE-1, the neurological center participating in the SPACE-2 trial will also be involved in the treatment
More informationIn cerebral embolism, recanaiization occurs very
680 Case Reports Recanaiization of Intracranial Carotid Occlusion Detected by Duplex Carotid Sonography Haruhiko Hoshino, MD, Makoto Takagi, MD, Ikuo Takeuchi, MD, Tsugio Akutsu, MD, Yasuyuki Takagi, MD,
More informationAtherosclerosis Regression An Overview of Recent Findings & Issues
Atherosclerosis Regression An Overview of Recent Findings & Issues 13th Angioplasty Summit 2008 Cheol Whan Lee, MD University of Ulsan, Asan Medical Center, Seoul, Korea CardioVascular Research Foundation
More informationHow would you manage Ms. Gold
How would you manage Ms. Gold 32 yo Asian woman with dyslipidemia Current medications: Simvastatin 20mg QD Most recent lipid profile: TC = 246, TG = 100, LDL = 176, HDL = 50 What about Mr. Williams? 56
More informationCho et al., 2009 Journal of Cardiology (2009), 54:
Endothelial Dysfunction, Increased Carotid Artery Intima-media Thickness and Pulse Wave Velocity, and Increased Level of Inflammatory Markers are Associated with Variant Angina Cho et al., 2009 Journal
More informationThe Accuracy of a Volume Plethysmography System as Assessed by Contrast Angiography
Research imedpub Journals http://www.imedpub.com/ DOI: 10.21767/2572-5483.100036 Journal of Preventive Medicine The Accuracy of a Volume Plethysmography System as Assessed by Contrast Angiography Andrew
More informationOriginal Research Article
A STUDY TO ESTIMATE SUBCLINICAL ATHEROSCLEROSIS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS BY MEASURING THE CAROTID INTIMAL MEDIAL THICKNESS Natarajan Kandasamy 1, Rajan Ganesan 2, Thilakavathi Rajendiran
More informationNomogram of the Relation of Brachial-Ankle Pulse Wave Velocity with Blood Pressure
801 Original Article Nomogram of the Relation of Brachial-Ankle Pulse Wave Velocity with Blood Pressure Akira YAMASHINA, Hirofumi TOMIYAMA, Tomio ARAI, Yutaka KOJI, Minoru YAMBE, Hiroaki MOTOBE, Zydem
More informationEzetimibe and SimvastatiN in Hypercholesterolemia EnhANces AtherosClerosis REgression (ENHANCE)
Ezetimibe and SimvastatiN in Hypercholesterolemia EnhANces AtherosClerosis REgression (ENHANCE) Thomas Dayspring, MD, FACP Clinical Assistant Professor of Medicine University of Medicine and Dentistry
More informationEpidemiologic and clinical comparison of renal artery stenosis in black patients and white patients
ORIGINAL ARTICLES Epidemiologic and clinical comparison of renal artery stenosis in black patients and white patients Andrew C. Novick, MD, Safwat Zald, MD, David Goldfarb, MD, and Ernest E. Hodge, MD,
More informationCarotid Artery Disease Assessed by Color Doppler Flow Imaging: Correlation with Standard Doppler Sonography and Angiography
259 Carotid Artery Disease Assessed by Color Doppler Flow Imaging: Correlation with Standard Doppler Sonography and Angiography.. Wolfgang Steinke 1 Christof Kloetzsch 1 Michael Hennerici 1 2 Carotid artery
More informationMeasure #195 (NQF 0507): Radiology: Stenosis Measurement in Carotid Imaging Reports National Quality Strategy Domain: Effective Clinical Care
Measure #195 (NQF 0507): Radiology: Stenosis Measurement in Carotid Imaging Reports National Quality Strategy Domain: Effective Clinical Care 2017 OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS ONLY MEASURE TYPE:
More informationIt is generally accepted that with most of the
846 Pulsed Multigated Doppler Ultrasonography in the Diagnosis of Carotid Artery Disease Henrik Sillesen, MD, Karen R. Bitsch, MD, Torben Schroeder, MD, Hans Jrgen Steenberg, MD, MSc, Linda Hansen, VT,
More informationCentral pressures and prediction of cardiovascular events in erectile dysfunction patients
Central pressures and prediction of cardiovascular events in erectile dysfunction patients N. Ioakeimidis, K. Rokkas, A. Angelis, Z. Kratiras, M. Abdelrasoul, C. Georgakopoulos, D. Terentes-Printzios,
More informationQuality ID #195 (NQF 0507): Radiology: Stenosis Measurement in Carotid Imaging Reports National Quality Strategy Domain: Effective Clinical Care
Quality ID #195 (NQF 0507): Radiology: Stenosis Measurement in Carotid Imaging Reports National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE
More informationCarotid arterial ultrasound scan imaging: A direct approach to stenosis measurement
Carotid arterial ultrasound scan imaging: A direct approach to stenosis measurement Hugh G. Beebe, MD, Sergio X. Salles-Cunha, PhD, Robert P. Scissons, RVT, Steven M. Dosick, MD, Ralph C. Whalen, MD, Steven
More informationReview of guidelines for management of dyslipidemia in diabetic patients
2012 international Conference on Diabetes and metabolism (ICDM) Review of guidelines for management of dyslipidemia in diabetic patients Nan Hee Kim, MD, PhD Department of Internal Medicine, Korea University
More informationORIGINAL INVESTIGATION. Carotid and Lower Extremity Arterial Disease in Patients With Renal Artery Atherosclerosis
ORIGINAL INVESTIGATION Carotid and Lower Extremity Arterial Disease in Patients With Renal Artery Atherosclerosis R. Eugene Zierler, MD; Robert O. Bergelin, MS; Nayak L. Polissar, PhD; Kirk W. Beach, PhD,
More informationAssociation between arterial stiffness and cardiovascular risk factors in a pediatric population
+ Association between arterial stiffness and cardiovascular risk factors in a pediatric population Maria Perticone Department of Experimental and Clinical Medicine University Magna Graecia of Catanzaro
More informationDisclosures. State of the Art Management of Carotid Stenosis. NIH funding for clinical trials Consultant for Scientia Vascular and Medtronic
State of the Art Management of Carotid Stenosis Mark R. Harrigan, MD UAB Stroke Center Professor of Neurosurgery, Neurology, and Radiology University of Alabama, Birmingham Disclosures NIH funding for
More informationCarotid Imaging. Dr Andrew Farrall. Consultant Neuroradiologist
20121123 SSCA http://www.neuroimage.co.uk/network Andrew Farrall Carotid Imaging Dr Andrew Farrall Consultant Neuroradiologist SFC Brain Imaging Research Centre (www.sbirc.ed.ac.uk), SINAPSE Collaboration
More informationARBITER 6-HALTS HDL And LDL Treatment Strategies
ARBITER 6-HALTS HDL And LDL Treatment Strategies Extended-Release Niacin or Ezetimibe and Carotid Intima Media Thickness Allen J. Taylor, M.D. Todd C. Villines, M.D. Eric J. Stanek, Pharm.D. Patrick J.
More informationSociety for Behavioral Medicine 33 rd Annual Meeting New Orleans, LA
Society for Behavioral Medicine 33 rd Annual Meeting New Orleans, LA John M. Violanti, PhD* a ; LuendaE. Charles, PhD, MPH b ; JaK. Gu, MSPH b ; Cecil M. Burchfiel, PhD, MPH b ; Michael E. Andrew, PhD
More informationObjective Calcium score carotid IMT hs-crp
P3952 Role of coronary calcium score, carotid intima-media thickness and C-reactive protein in predicting extent of coronary artery disease in young patients. Bedside Poster P3952 Role of coronary calcium
More informationThe correlation between the severity of peripheral arterial disease and carotid occlusive disease
The correlation between the severity of peripheral arterial disease and carotid occlusive disease Tayler H Long a, Michael H Criqui b, Eduard E Vasilevskis c, Julie O Denenberg b, Melville R Klauber b
More informationCarotid Artery Velocity Patterns in Normal and Stenotic Vessels
Carotid Artery Velocity Patterns in Normal and Stenotic Vessels 67 W. M. BLACKSHEAR, JR., M.D., D. J. PHLLPS, PH.D., P. M. CHKOS, M.D., J. D. HARLEY, M.D., B. L. THELE, M.B.B.S., AND D. E. STRANDNESS,
More informationColor Doppler Imaging Evaluation of Proximal Vertebral Artery Stenosis
Vascular and Interventional Radiology Original Research Hua et al. Color Doppler Imaging of Proximal Vertebral Artery Stenosis Vascular and Interventional Radiology Original Research Yang Hua 1 Xiu-Feng
More informationBeyond Stenosis Severity: Top 5 Important Duplex Characteristics to Identify in a Patient with Carotid Disease
Beyond Stenosis Severity: Top 5 Important Duplex Characteristics to Identify in a Patient with Carotid Disease Jan M. Sloves RVT, RCS, FASE Technical Director New York Cardiovascular Associates Disclosures
More informationHow to detect early atherosclerosis ; focusing on techniques
How to detect early atherosclerosis ; focusing on techniques Jang-Ho Bae, MD., PhD. Heart Center Konyang University Hospital Daejeon city, S. Korea Surrogates for Atherosclerosis Measures of endothelial
More informationCLINICAL STUDY. Yasser Khalil, MD; Bertrand Mukete, MD; Michael J. Durkin, MD; June Coccia, MS, RVT; Martin E. Matsumura, MD
117 CLINICAL STUDY A Comparison of Assessment of Coronary Calcium vs Carotid Intima Media Thickness for Determination of Vascular Age and Adjustment of the Framingham Risk Score Yasser Khalil, MD; Bertrand
More informationRadiologic Importance of a High- Resistive Vertebral Artery Doppler Waveform on Carotid Duplex Ultrasonography
CME Article Radiologic Importance of a High- Resistive Vertebral Artery Doppler Waveform on Carotid Duplex Ultrasonography Esther S. H. Kim, MD, MPH, Megan Thompson, Kristine M. Nacion, BA, Carmel Celestin,
More informationThe New England Journal of Medicine CUMULATIVE EFFECTS OF HIGH CHOLESTEROL LEVELS, HIGH BLOOD PRESSURE, AND CIGARETTE SMOKING ON CAROTID STENOSIS
CUMULATIVE EFFECTS OF HIGH CHOLESTEROL LEVELS, HIGH BLOOD PRESSURE, AND CIGARETTE SMOKING ON CAROTID STENOSIS PETER W.F. WILSON, M.D., JEFFREY M. HOEG, M.D., RALPH B. D AGOSTINO, PH.D., HALIT SILBERSHATZ,
More informationSimvastatin With or Without Ezetimibe in Familial Hypercholesterolemia
Simvastatin With or Without Ezetimibe in Familial Hypercholesterolemia The trial ClinicalTrials.gov number: NCT00552097 John J.P. Kastelein, MD, PhD* Department of Vascular Medicine Academic Medical Center
More informationSpotty Calcification as a Marker of Accelerated Progression of Coronary Atherosclerosis : Insights from Serial Intravascular Ultrasound
Spotty Calcification as a Marker of Accelerated Progression of Coronary Atherosclerosis : Insights from Serial Intravascular Ultrasound Department of Cardiovascular Medicine Heart and Vascular Institute
More information3/25/2010. Age-adjusted incidence rates for coronary heart disease according to body mass index and waist circumference tertiles
Outline Relationships among Regional Adiposity, Physical Activity, and CVD Risk Factors: Preliminary Results from Two Epidemiologic Studies Molly Conroy, MD, MPH Obesity Journal Club February 18, 2010
More informationLandmesser U et al. Eur Heart J 2017; https://doi.org/ /eurheartj/ehx549
2017 Update of ESC/EAS Task Force on Practical Clinical Guidance for PCSK9 inhibition in Patients with Atherosclerotic Cardiovascular Disease or in Familial Hypercholesterolaemia Cardiovascular Outcomes
More informationThe Framingham Coronary Heart Disease Risk Score
Plasma Concentration of C-Reactive Protein and the Calculated Framingham Coronary Heart Disease Risk Score Michelle A. Albert, MD, MPH; Robert J. Glynn, PhD; Paul M Ridker, MD, MPH Background Although
More informationProblems of Carotid Doppler Scanning Which Can Be Overcome by Using Frequency Analysis
Problems of Carotid Doppler Scanning Which Can Be Overcome by Using Frequency Analysis K. W. JOHNSTON, M.D., F.R.C.S.(C), F.A.C.S., P. M. BROWN, M.D., F.R.C.S.(C), AND M. KASSAM, M.A.SC. SUMMARY The value
More informationHIGH LDL CHOLESTEROL IS NOT AN INDEPENDENT RISK FACTOR FOR HEART ATTACKS AND STROKES
HIGH LDL CHOLESTEROL IS NOT AN INDEPENDENT RISK FACTOR FOR HEART ATTACKS AND STROKES A study published in the British Medical Journal shows that not only is high LDL cholesterol not a risk factor for all-caused
More informationProfile of Extracranial Cerebrovascular Disease in Kelantan: A Study by Continuous Wave Doppler Ultrasonography
---- ------ - ------------- Profile of Extracranial Cerebrovascular Disease in Kelantan: A Study by Continuous Wave Doppler Ultrasonography R.c. Pratap, MD M. Mafauzy, MRCP Department of Medicine, University
More informationAbstract nr AHA, Chicago November European Heart Journal Cardiovascular Imaging, in press. Nr Peter Blomstrand
Left Ventricular Diastolic Function Assessed by Echocardiography and Tissue Doppler Imaging is a strong Predictor of Cardiovascular Events in Patients with Diabetes Mellitus Type 2 Peter Blomstrand, Martin
More informationImaging for Peripheral Vascular Disease
Imaging for Peripheral Vascular Disease James G. Jollis, MD Director, Rex Hospital Cardiovascular Imaging Imaging for Peripheral Vascular Disease 54 year old male with exertional calf pain in his right
More informationEvaluation of Carotid Vessels and Vertebral Artery in Stroke Patients with Color Doppler Ultrasound and MR Angiography
Evaluation of Carotid Vessels and Vertebral Artery in Stroke Patients with Color Doppler Ultrasound and MR Angiography Dr. Pramod Shaha 1, Dr. Vinay Raj R 2, Dr. (Brig) K. Sahoo 3 Abstract: Aim & Objectives:
More informationCarotid Artery Stenting (CAS) Pathophysiology. Technical Considerations. Plaque characteristics: relevant concepts. CAS and CEA
Carotid Artery Stenting (CAS) Carotid Artery Stenting for Stroke Risk Reduction Matthew A. Corriere MD, MS, RPVI Assistant Professor of Surgery Department of Vascular and Endovascular Surgery Rationale:
More informationIndividuals of African and African Caribbean descent living
ORIGINAL RESEARCH A.D. Mackinnon P. Jerrard-Dunne L. Porteous H.S. Markus Carotid Intima-Media Thickness is Greater but Carotid Plaque Prevalence is Lower in Black Compared with White Subjects BACKGROUND
More informationKatsuyuki Nakajima, PhD. Member of JCCLS International Committee
Katsuyuki Nakajima, PhD Member of JCCLS International Committee Visiting Professor and Scientist Tufts University, Boston, MA & Framingham Offspring Study, Framingham, MA August 20 th, 2011, Tokyo Framingham
More informationFamilial hypercholesterolemia in childhood: diagnostics, therapeutical options and risk stratification Rodenburg, J.
UvADARE (Digital Academic Repository) Familial hypercholesterolemia in childhood: diagnostics, therapeutical options and risk stratification Rodenburg, J. Link to publication Citation for published version
More informationNatural history of atherosclerotic renal artery stenosis: A prospective study with duplex ultrasonography
Natural history of atherosclerotic renal artery stenosis: A prospective study with duplex ultrasonography R. Eugene Zierler, MD, Robert o. Bergelin, MS, Janette A. Isaacson, RVT, and D. Eugene Strandness,
More informationSTUDIES ON ARTERIAL ENDOTHELIAL FUNCTION AND INTIMA- MEDIA THICKNESS USING ULTRASOUND TECHNIQUE. Morteza Rohani
STUDIES ON ARTERIAL ENDOTHELIAL FUNCTION AND INTIMA- MEDIA THICKNESS USING ULTRASOUND TECHNIQUE Morteza Rohani Stockholm 2008 DEPARTMENT OF MEDICINE, HUDDINGE KAROLINSKA INSTITUTET, STOCKHOLM, SWEDEN STUDIES
More informationThe association of the total cardiovascular risk and non-invasive markers of atherosclerosis with the extent of coronary artery disease
The association of the total cardiovascular risk and non-invasive markers of atherosclerosis with the extent of coronary artery disease S. Kostic 1, D. Mijalkovic 1, D. Djordjevic 2, T. Savic 2, D. Lovic
More informationRates and Determinants of Site-Specific Progression of Carotid Artery Intima-Media Thickness. The Carotid Atherosclerosis Progression Study
Rates and Determinants of Site-Specific Progression of Carotid Artery Intima-Media Thickness The Carotid Atherosclerosis Progression Study Andrew D. Mackinnon, MRCP; Paula Jerrard-Dunne, MRCPI; Matthias
More informationPCSK9 Inhibitors and Modulators
PCSK9 Inhibitors and Modulators Pam R. Taub MD, FACC Director of Step Family Cardiac Rehabilitation and Wellness Center Associate Professor of Medicine UC San Diego Health System Disclosures Speaker s
More informationEffects of Statins on Endothelial Function in Patients with Coronary Artery Disease
Effects of Statins on Endothelial Function in Patients with Coronary Artery Disease Iana I. Simova, MD; Stefan V. Denchev, PhD; Simeon I. Dimitrov, PhD Clinic of Cardiology, University Hospital Alexandrovska,
More informationVascular Ultrasound: Current state, current needs, future directions
Vascular Ultrasound: Current state, current needs, future directions Laurence Needleman, MD Thomas Jefferson University Hospitals Sidney Kimmel Medical College of Thomas Jefferson University Disclosures
More information2010 Korean Society of Cardiology Spring Scientific Session Korea Japan Joint Symposium. Seoul National University Hospital Cardiovascular Center
2010 Korean Society of Cardiology Spring Scientific Session Korea Japan Joint Symposium Does Lt Late Cth Catch up Exist Eiti in DES? : Quantitative Coronary Angiography Analysis Kyung Woo Park, MD Cardiovascular
More informationPrevalence of carotid artery stenosis in Chinese patients with angina pectoris
Original Article Prevalence of carotid artery stenosis in Chinese patients with angina pectoris Jianbin Zhang*, Rongwei Xu*, Peng Liu, Xueqiang Fan, Zhidong Ye Department of Cardiovascular Surgery, China-Japan
More information